Frazier Life Sciences Management, L.P.

Q1 2025 13F Holdings Report, Stock Holdings

Signature - Title
Steve R. Bailey - Chief Financial Officer and Chief Compliance Officer
Location
Palo Alto, CA
Holdings as of
March 31, 2025
Value $
$2.19B
Num holdings
47
Date filed
5/15/2025, 04:41 PM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included NAMS, MIRM, VRNA, ARQT, and BBIO.
Previous filing
Q4 2024 - Feb 18, 2025
Filing 2025 Q1 compared to 2024 Q4 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Steve R. Bailey Chief Financial Officer and Chief Compliance Officer Seattle, Washington 5/15/2025